Moxtek, Philips to Co-Develop Wire-Grid Microarray Platform for Outlicensing | GenomeWeb

Looking to extend its nanophotonics business into the life-sciences market, Moxtek last week announced that it is co-developing with Philips Research a new microarray platform that it intends to outlicense to an as-yet unidentified life sciences player.

The platform, called the wire-grid microarray chip, will be designed to offer high surface-specificity and suppression of background signals, and could provide improved quantitative detection of biomolecules such as proteins and nucleic acids, the firms said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.